Johnson & Johnson EVP sells 23,054 shares

Rhea-AI Filing Summary

Vanessa Broadhurst, EVP, Global Corp Affairs at Johnson & Johnson, exercised employee stock options for 11,129 and 11,925 shares of Common Stock on July 20, 2026 at exercise prices of $129.5100 and $131.9400 per share, then sold 23,054 shares in transactions described as open market or private at a weighted average price of $251.2660 per share. These options were awarded under the issuer's Long-Term Incentive Plan and become exercisable on the third anniversary of the grant date.

Insider Trade Summary

Exercise and Sale: 23,054 shares ($2.78M approx. pre-tax spread)

Exercise and Sale 5 txns

Insider Broadhurst Vanessa

Role EVP, Global Corp Affairs

Sold 23,054 shs ($5.79M)

Approx. gross sale proceeds $5.79M

Approx. exercise cost $3.01M

Approx. pre-tax spread $2.78M

Type	Security	Shares	Price	Value
Exercise	Employee Stock Options (Right to Buy) F2	11,129	$0.00	$0.00
Exercise	Employee Stock Options (Right to Buy) F2	11,925	$0.00	$0.00
Exercise	Common Stock	11,129	$129.51	$1.44M
Exercise	Common Stock	11,925	$131.94	$1.57M
Sale	Common Stock F1	23,054	$251.266	$5.79M

Holdings After Transaction: Employee Stock Options (Right to Buy) — 0 contracts (Direct); Common Stock — 23,003 shares (Direct)

Footnotes (2)

1. F1. This transaction was executed in multiple trades at prices ranging from $251.09 to $251.555. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
2. F2. Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.

Key Figures

Common shares sold: 23054 shares Weighted average sale price: $251.2660 per share Options exercised (2021 grant): 11129 shares +3 more

6 metrics

Common shares sold 23054 shares Common Stock sale on 2026-07-20 at weighted average $251.2660 per share

Weighted average sale price $251.2660 per share Price for 23,054-share sale, with individual trades between $251.09 and $251.555

Options exercised (2021 grant) 11129 shares Employee Stock Options (Right to Buy) exercised at $129.5100 per share, expiring 2028-02-11

Exercise price, 2021 grant $129.5100 per share Conversion of Employee Stock Options into 11,129 Common Stock shares on 2026-07-20

Options exercised (2022 grant) 11925 shares Employee Stock Options (Right to Buy) exercised at $131.9400 per share, expiring 2029-02-11

Exercise price, 2022 grant $131.9400 per share Conversion of Employee Stock Options into 11,925 Common Stock shares on 2026-07-20

Key Terms

Employee Stock Options (Right to Buy), Long-Term Incentive Plan, weighted average sale price

3 terms

Employee Stock Options (Right to Buy) financial

"security_title shows Employee Stock Options (Right to Buy) on derivative rows"

Long-Term Incentive Plan financial

"Footnote F2 states awards were under the Issuer's Long-Term Incentive Plan"

A long-term incentive plan is a company program that pays executives or employees with stock, options, or cash tied to multi-year performance goals, where the rewards become theirs only after meeting conditions over time. Think of it as a delayed bonus or retirement-style reward that aligns employees’ interests with shareholders by encouraging them to boost long-term value; investors watch these plans because they affect pay costs, share dilution and management incentives.

weighted average sale price financial

"Footnote F1 explains the price is a weighted average sale price over multiple trades"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transactions did Vanessa Broadhurst report for Johnson & Johnson (JNJ)?

Vanessa Broadhurst reported exercising employee stock options for 11,129 and 11,925 Johnson & Johnson shares and then selling 23,054 Common Stock shares. The sale used a weighted average price of $251.2660 per share across multiple trades on July 20, 2026.

How many Johnson & Johnson (JNJ) shares did Vanessa Broadhurst sell and at what price?

She sold 23,054 shares of Johnson & Johnson Common Stock at a weighted average price of $251.2660 per share. Footnote disclosure states the trades were executed between $251.09 and $251.555, with the reported price reflecting the weighted average sale price.

What stock options did Vanessa Broadhurst exercise in this JNJ Form 4 filing?

She exercised 11,129 Employee Stock Options at an exercise price of $129.5100 per share and 11,925 Employee Stock Options at $131.9400 per share. Both option awards were granted under the issuer's Long-Term Incentive Plan and have stated expiration dates in 2028 and 2029.

Under what plan were the options in Vanessa Broadhurst’s JNJ filing granted?

Footnote F2 states the stock option awards were granted under Johnson & Johnson's Long-Term Incentive Plan. The plan provides that each Stock Option Award vests and is exercisable on the third anniversary of the grant date before the stated expiration.

Were Vanessa Broadhurst’s JNJ share sales single-price or multiple trades?

The sale was executed in multiple trades, not a single-price block. Footnote F1 explains the transactions occurred at prices ranging from $251.09 to $251.555, with the Form 4 reporting a weighted average sale price of $251.2660 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/21/2026 - 05:27 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Broadhurst Vanessa

(Last) (First) (Middle)

ONE JOHNSON & JOHNSON PLAZA

(Street)

NEW BRUNSWICK NEW JERSEY 08933

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
JOHNSON & JOHNSON [ JNJ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Global Corp Affairs

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/20/2026		M		11,129	A	$129.51	34,132	D
Common Stock	07/20/2026		M		11,925	A	$131.94	46,057	D
Common Stock	07/20/2026		S		23,054	D	$251.266(1)	23,003	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Options (Right to Buy)	$129.51	07/20/2026		M			11,129	02/12/2021(2)	02/11/2028	Common Stock	11,129	$0	0	D
Employee Stock Options (Right to Buy)	$131.94	07/20/2026		M			11,925	02/11/2022(2)	02/11/2029	Common Stock	11,925	$0	0	D

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $251.09 to $251.555. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

2. Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.

Remarks:

	/s/ Joleen Morgan, as attorney-in-fact for Vanessa Broadhurst	07/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)